Long-term colorectal cancer incidence and mortality after screening colonoscopy: The NordICC randomized trial
In this medfyle
Colonoscopy is widely used as a screening test for colorectal cancer, but precise quantification of its benefits have been hampered by the absence of randomized trials with long-term follow-up. Now, 10-year data from the NordICC trial confirm one-off screening with colonoscopy reduces the incidence of both colorectal cancer and mortality.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Expert commentary
About this Medfyle
This is a summary of an oral session given at the UEG Week 2022 and presented by:
Dr. Michael Bretthauer
University of Oslo
Oslo, Norway
The content is produced by Infomedica. The presenting authors of the original session had no part in the creation of this conference summary.
In addition, an expert commentary on the topic has been provided by:
